Advanced in Glaucoma

Dr. Kenneth N. Sall

Ophthalmology
11423 187th St, Suite 200, 
Artesia, CA 
Advanced in Glaucoma
11423 187th St, Suite 200, 
Artesia, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Kenneth Sall is an Ophthalmologist in Artesia, California. Dr. Sall is rated as an Advanced provider by MediFind in the treatment of Glaucoma. His top areas of expertise are Ocular Hypertension (OHT), Dry Eye Syndrome, Pigment-Dispersion Syndrome, Glaucoma, and Cataract Removal.

His clinical research consists of co-authoring 18 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles in the study of Glaucoma.

Specialties
Ophthalmology
Licenses
Ophthalmology in CA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

11423 187th St, Suite 200, Artesia, CA 90701

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Enrollment Status: Completed
Publish Date: February 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase III, Double-Masked, Randomized, Controlled Trial of KPI-121 in Postsurgical Inflammation
A Phase III, Double-Masked, Randomized, Controlled Trial of KPI-121 in Postsurgical Inflammation
Enrollment Status: Completed
Publish Date: January 29, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Enrollment Status: Completed
Publish Date: January 05, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Double-Masked, Randomized, Controlled Study to Evaluate the Safety and Efficacy of KPI-121 1.0% Ophthalmic Suspension in Subjects With Postsurgical Inflammation and Pain
A Phase 3, Double-Masked, Randomized, Controlled Study to Evaluate the Safety and Efficacy of KPI-121 1.0% Ophthalmic Suspension in Subjects With Postsurgical Inflammation and Pain
Enrollment Status: Completed
Publish Date: December 16, 2020
Intervention Type: Drug
Study Phase: Phase 3
Randomized, Double-Masked, Parallel Group Study of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Assessing Safety and Efficacy Over 28 Days
Randomized, Double-Masked, Parallel Group Study of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Assessing Safety and Efficacy Over 28 Days
Enrollment Status: Terminated
Publish Date: October 11, 2018
Intervention Type: Drug
Study Phase: Phase 2
A Single Arm, Multicenter, Open-Label Study Designed to Evaluate Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator
A Single Arm, Multicenter, Open-Label Study Designed to Evaluate Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator
Enrollment Status: Completed
Publish Date: October 25, 2017
Intervention Type: Device
Study Phase: Not Applicable
View 5 Less Clinical Trials

18 Total Publications

A Phase IIa Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent Pterygium.
A Phase IIa Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent Pterygium.
Journal: Ophthalmology science
Published: August 08, 2023
Similar Doctors
Elite in Glaucoma
Dr. Joseph Caprioli
Ophthalmology
Elite in Glaucoma
Dr. Joseph Caprioli
Ophthalmology

Jules Stein Eye Institute Medical Group

622 W Duarte Rd, Suite 101, 
Arcadia, CA 
 (18.3 miles away)
323-442-7122
Experience:
47+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Joseph Caprioli is an Ophthalmologist in Arcadia, California. Dr. Caprioli has been practicing medicine for over 47 years and is rated as an Elite provider by MediFind in the treatment of Glaucoma. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Cataract Removal.

Elite in Glaucoma
Dr. Simon K. Law
Ophthalmology
Elite in Glaucoma
Dr. Simon K. Law
Ophthalmology

Jules Stein Eye Institute Medical Group

622 W Duarte Rd, Suite 101, 
Arcadia, CA 
 (18.3 miles away)
323-442-7122
Experience:
47+ years
Languages Spoken:
English
See accepted insurances

Simon Law is an Ophthalmologist in Arcadia, California. Dr. Law has been practicing medicine for over 47 years and is rated as a Distinguished provider by MediFind in the treatment of Glaucoma. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Vitrectomy.

Elite in Glaucoma
Dr. Benjamin Y. Xu
Ophthalmology
Elite in Glaucoma
Dr. Benjamin Y. Xu
Ophthalmology

USC Care Medical Group Inc

1520 San Pablo St, Fl 4, 
Los Angeles, CA 
 (15.3 miles away)
800-872-2273
Languages Spoken:
English
See accepted insurances

Benjamin Xu is an Ophthalmologist in Los Angeles, California. Dr. Xu is rated as a Distinguished provider by MediFind in the treatment of Glaucoma. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Iridectomy, and Trabeculectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sall's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile